Brief: Nektar Therapeutics To Offer Up To $150 Million In Common Stock Via Equity Distribution Agreement - SEC Filing
08/05/2026 22:13
May 8 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS - TO OFFER UP TO $150 MILLION IN COMMON STOCK VIA EQUITY DISTRIBUTION AGREEMENT - SEC FILING NEKTAR THERAPEUTICS - SANDRA GARDINER TO RETIRE AS INTERIM CFO EFFECTIVE MAY 15, 2026 - SEC FILING NEKTAR THERAPEUTICS - APPOINTS LINDA RUBINSTEIN AS INTERIM CFO EFFECTIVE MAY 15, 2026 - SEC FILING Source text: [ID:n0001193125-26-214976] Further company coverage: NKTR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says